Completed NA INTERVENTIONAL 2-arm NCT02516072

Use of Remote Ischaemic Preconditioning in the Prevention of Contrast Induced Nephropathy

The Use of Remote Ischaemic Preconditioning in the Prevention of Contrast Induced Nephropathy in Patients Undergoing Elective Diagnostic or Therapeutic Peripheral Angiography: a Pilot Randomised Controlled Trial

Sponsor: Changi General Hospital

Conditions Contrast Induced Nephropathy Remote Ischaemic Preconditioning

Interventions RIPC

Updated 7 times since 2017 Last updated: Jan 22, 2020 Started: Jan 31, 2015 Primary completion: Dec 30, 2016 Completion: Sep 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02516072, this NA trial focuses on Contrast Induced Nephropathy and Remote Ischaemic Preconditioning and remains completed. Sponsored by Changi General Hospital, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Jun 2019 — Feb 2020 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Jun 2018 — Jun 2019 [monthly]

Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Changi General Hospital
University College Hospital Galway

Data source: Changi General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Singapore, Singapore